HYDERABAD, India, November 8, 2016 /PRNewswire/ --
According to the report "Global Monoclonal Antibodies Market",published by Market Data Forecast, the global market is projected to reach USD 112.18 billion by 2021, at a CAGR of 5.30% from 2016 to 2021.
(Logo: http://photos.prnewswire.com/prnh/20160913/406914LOGO )
For full report refer to
Free sample for the report is available at "http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/request-sample"
mAbs are antibodies produced by a single clone of cells consisting of identical antibody molecules. Global Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications. At present, there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases, and many of these products have also been approved in the global markets. At the current approval rate of four new products releasing every year, approximately 70 monoclonal antibody products are expected to be present on the market by 2020.
Global Monoclonal Antibodies market is driven by increasing R & D activities in genomics, owing to rapid advancements of our understanding of disease at a molecular level. The development of new molecules is expected to play a prominent role in the future of the market due to the cost effectiveness of this technology. However huge cost and time associated with the identification and development of potential molecules is a major factor hindering the growth of the market.
Enquire more before buying at "http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/inquire"
By End User
Enquire more about the report at "insert link"
Some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co., Ltd. (China).
Buy now "https://www.marketdataforecast.com/cart/buy-now/global-monoclonal-antibodies-market-1184"
The Global Monoclonal Antibodies Market Study covers:
Checkout other related studies in the Pharmaceuticals Segment:
Autoimmune Monoclonal Antibodies Market:
Bio Pharmaceuticals Market:
Cancer Monoclonal Antibodies Market:
Immunotherapy Drugs Market:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact: Abhishek Shukla Team Lead (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: firstname.lastname@example.org
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
SOURCE Market Data Forecast
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All